| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |